Korean Neurotoxin Injectables

Face Forward Aesthetics Adds Letybo Across Eight Clinics

Face Forward Aesthetics is expanding its injectable lineup with 'Letybo,' a Hugel neurotoxin for adults seeking temporary softening of moderate to severe lines between the brows. The FDA-approved treatment gives the nurse practitioner-led practice another way to match wrinkle injections to a guest's goals and medical history.

The treatment is being added across eight Face Forward clinics in Ohio, Pennsylvania, and Nevada. Marketed as 'K-Tox,' Letybo is South Korea's top-selling neurotoxin. It has more than 15 years of clinical use globally, giving patients a Korean-developed option with an established track record.

Availability across eight clinics turns a single-product add into broader regional access, helping Face Forward widen choice without changing its consultation-led model. An FDA-approved Korean brand also brings Korean beauty influence into injectable menus, not just skin-care routines.

Image Credit: Face Forward® Aesthetics

K-beauty Injectables
Korean-developed neurotoxins extend K-beauty influence into medical aesthetics, creating room for globally proven treatments to reshape consumer expectations beyond topical skincare.
Personalized Neurotoxin Menus
Expanded injectable portfolios support more tailored treatment matching based on patient goals, medical history, and desired wrinkle-softening outcomes.
Regional Aesthetic Access
Multi-clinic rollouts turn niche aesthetic products into accessible regional offerings, widening patient choice without requiring major changes to care models.

Who This Affects Most

Medical Aesthetics
FDA-approved international neurotoxins introduce fresh competitive dynamics for clinics seeking differentiated wrinkle-relaxing treatments.
Beauty and Personal Care
The movement of Korean beauty credibility into injectables blurs the line between skincare culture and clinical cosmetic procedures.
Healthcare Retail
Nurse practitioner-led clinic networks demonstrate how specialty treatments can scale through localized, consultation-based service models.
SCORE
7.8 out of 10
GENDER
30% Men70% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 75%
Activity 58%
Freshness 100%